Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Brookline Capital Downgrades Forte Biosciences to Hold

Brookline Capital analyst Kumaraguru Raja downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

September 3, 2021

1 minute read

Brookline Capital analyst Kumaraguru Raja downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

Why GE Is Trading Higher On Tuesday Premarket?

Today, 1:56 PM

General Electric Co (NYSE:GE) plans to form three global public companies focused on the growth sectors of aviation, healthcare, and energy.…

Today, 1:56 PM

Raymond James analyst John Ransom maintains Health Catalyst (NASDAQ:HCAT) with a Strong Buy and lowers the price target from $70 to $40.

Today, 1:56 PM

-Reuters

Today, 1:56 PM

Panasonic Holdings Corp (OTC:PCRFY) was finalizing its decision regarding the U.S. site for its new battery plant, Reuters reports citing Panasonic…